Details

Title
Addendum to: Improved CRISPR genome editing using small highly active and specific engineered RNA-guided nucleases
Author
Schmidt, Moritz J. 1 ; Gupta, Ashish 1 ; Bednarski, Christien 1 ; Gehrig-Giannini, Stefanie 1 ; Richter, Florian 1 ; Pitzler, Christian 1 ; Gamalinda, Michael 1 ; Galonska, Christina 1 ; Takeuchi, Ryo 2 ; Wang, Kui 2 ; Reiss, Caroline 2 ; Dehne, Kerstin 1 ; Lukason, Michael J. 3 ; Noma, Akiko 2 ; Park-Windhol, Cindy 2 ; Allocca, Mariacarmela 2 ; Kantardzhieva, Albena 2 ; Sane, Shailendra 2 ; Kosakowska, Karolina 2 ; Cafferty, Brian 2 ; Tebbe, Jan 1 ; Spencer, Sarah J. 3 ; Munzer, Scott 2 ; Cheng, Christopher J. 2 ; Scaria, Abraham 2 ; Scharenberg, Andrew M. 2 ; Cohnen, André 1   VIAFID ORCID Logo  ; Coco, Wayne M. 1   VIAFID ORCID Logo 

 Bayer AG, Leverkusen, Germany (GRID:grid.420044.6) (ISNI:0000 0004 0374 4101) 
 Casebia Therapeutics LLC, Cambridge, USA (GRID:grid.420044.6) 
 CRISPR Therapeutics INC, Cambridge, USA (GRID:grid.420044.6) 
Pages
3503
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2825595648
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.